These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6087329)

  • 1. Nuclease S1 mapping of a homozygous mutation in the carboxyl-propeptide-coding region of the pro alpha 2(I) collagen gene in a patient with osteogenesis imperfecta.
    Dickson LA; Pihlajaniemi T; Deak S; Pope FM; Nicholls A; Prockop DJ; Myers JC
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4524-8. PubMed ID: 6087329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular defect in an autosomal dominant form of osteogenesis imperfecta. Synthesis of type I procollagen containing cysteine in the triple-helical domain of pro-alpha 1(I) chains.
    de Vries WN; de Wet WJ
    J Biol Chem; 1986 Jul; 261(19):9056-64. PubMed ID: 3722186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation.
    Pihlajaniemi T; Dickson LA; Pope FM; Korhonen VR; Nicholls A; Prockop DJ; Myers JC
    J Biol Chem; 1984 Nov; 259(21):12941-4. PubMed ID: 6092353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single base mutation in the pro alpha 2(I) collagen gene that causes efficient splicing of RNA from exon 27 to exon 29 and synthesis of a shortened but in-frame pro alpha 2(I) chain.
    Tromp G; Prockop DJ
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5254-8. PubMed ID: 2839839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro alpha 1 (I) chain carboxyl-terminal propeptide which impair subunit assembly.
    Lamandé SR; Chessler SD; Golub SB; Byers PH; Chan D; Cole WG; Sillence DO; Bateman JF
    J Biol Chem; 1995 Apr; 270(15):8642-9. PubMed ID: 7721766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen.
    Deak SB; Nicholls A; Pope FM; Prockop DJ
    J Biol Chem; 1983 Dec; 258(24):15192-7. PubMed ID: 6418743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal procollagen synthesis in fibroblasts from three patients of the same family with a severe form of osteogenesis imperfecta (type III).
    Bonaventure J; Cohen-Solal L; Lasselin C; Allain JC; Maroteaux P
    Biochim Biophys Acta; 1986 Oct; 889(1):23-34. PubMed ID: 3768427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis.
    Tenni R; Cetta G; Dyne K; Rossi A; Quacci D; Lenzi L; Castellani AA
    Hum Genet; 1988 Jul; 79(3):245-50. PubMed ID: 3402997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of the gene for the pro alpha 1(IV) chain of basement-membrane procollagen in cultured skin fibroblasts from two variants of osteogenesis imperfecta.
    Pihlajaniemi T; McKeon J; Gay S; Gay R; de Wet WJ; Myers JC; Prockop DJ
    Biochem J; 1989 Jan; 257(2):439-45. PubMed ID: 2649075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A frameshift mutation results in a truncated nonfunctional carboxyl-terminal pro alpha 1(I) propeptide of type I collagen in osteogenesis imperfecta.
    Bateman JF; Lamande SR; Dahl HH; Chan D; Mascara T; Cole WG
    J Biol Chem; 1989 Jul; 264(19):10960-4. PubMed ID: 2500431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of mutant alpha (I)-procollagen in osteoblast and fibroblast cultures from a proband with osteogenesis imperfecta type IV.
    Chipman SD; Shapiro JR; McKinstry MB; Stover ML; Branson P; Rowe DW
    J Bone Miner Res; 1992 Jul; 7(7):793-805. PubMed ID: 1642148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a pro-alpha 2(I) collagen gene mutation by nuclease S1 mapping.
    Pihlajaniemi T; Myers JC
    Methods Enzymol; 1987; 145():213-22. PubMed ID: 3037272
    [No Abstract]   [Full Text] [Related]  

  • 13. Type I osteogenesis imperfecta: a nonfunctional allele for pro alpha 1 (I) chains of type I procollagen.
    Barsh GS; David KE; Byers PH
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3838-42. PubMed ID: 6954526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta.
    Nicholls AC; Osse G; Schloon HG; Lenard HG; Deak S; Myers JC; Prockop DJ; Weigel WR; Fryer P; Pope FM
    J Med Genet; 1984 Aug; 21(4):257-62. PubMed ID: 6492090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the carboxyl-terminal propeptide of the pro alpha 1(I) chain of type I collagen result in defective chain association and produce lethal osteogenesis imperfecta.
    Chessler SD; Wallis GA; Byers PH
    J Biol Chem; 1993 Aug; 268(24):18218-25. PubMed ID: 8349697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A point mutation in a type I procollagen gene converts glycine 748 of the alpha 1 chain to cysteine and destabilizes the triple helix in a lethal variant of osteogenesis imperfecta.
    Vogel BE; Minor RR; Freund M; Prockop DJ
    J Biol Chem; 1987 Oct; 262(30):14737-44. PubMed ID: 3667599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 9-base pair deletion in COL1A1 in a lethal variant of osteogenesis imperfecta.
    Hawkins JR; Superti-Furga A; Steinmann B; Dalgleish R
    J Biol Chem; 1991 Nov; 266(33):22370-4. PubMed ID: 1939261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A de novo G to T transversion in a pro-alpha 1 (I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain.
    Valli M; Mottes M; Tenni R; Sangalli A; Gomez Lira M; Rossi A; Antoniazzi F; Cetta G; Pignatti PF
    J Biol Chem; 1991 Jan; 266(3):1872-8. PubMed ID: 1988452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular heterogeneity in osteogenesis imperfecta type I.
    Willing MC; Pruchno CJ; Byers PH
    Am J Med Genet; 1993 Jan; 45(2):223-7. PubMed ID: 8456806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and processing of a type I procollagen containing shortened pro-alpha 1(I) chains by fibroblasts from a patient with osteogenesis imperfecta.
    Williams CJ; Prockop DJ
    J Biol Chem; 1983 May; 258(9):5915-21. PubMed ID: 6304100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.